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Abstract 
Mononuclear silver(I) complexes with 1,7-phenanthroline (1,7-phen), [Ag(NO3-O,O’)(1,7-
phen-N7)2] (1) and [Ag(1,7-phen-N7)2]X, X = ClO4
-
 (2), CF3SO3
-
 (3), BF4
-
 (4)  and SbF6
-
 
(5) were synthesized and structurally characterized by NMR (
1
H and 
13
C), IR and UV-Vis 
spectroscopy and ESI mass spectrometry. The crystal structures of 1, 3 and 4 were 
determined by single-crystal X-ray diffraction analysis. In all these complexes, 1,7-phen 
coordinates to the Ag(I) ion in a monodentate fashion via the less sterically hindered N7 
nitrogen atom. The investigation of the solution stability of 1 – 5 in DMSO revealed that 
they are sufficiently stable in this solvent at room temperature. Complexes 1 – 5 showed 
selectivity towards Candida spp. in comparison to bacteria, effectively inhibiting the 
growth of four different Candida species with minimal inhibitory concentrations (MIC) 
between 1.2 and 11.3 µM. Based on the lowest MIC values and the lowest cytotoxicity 
against healthy human fibroblasts with selectivity index of more than 30, the antifungal 
potential was examined in detail for the complex 1. It had the ability to attenuate C. 
albicans virulence and to reduce epithelial cell damage in the cell infection model. 
Induction of reactive oxygen species (ROS) response has been detected in C. albicans, 
with fungal DNA being one of the possible target biomolecules. The toxicity profile of 1 in 
the zebrafish model (Danio rerio) revealed improved safety and activity in comparison to 
that of clinically utilized silver(I) sulfadiazine. 
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Fig. S1. Molecular structure of the silver(I) complex 3. Non-coordinating triflate anion in 3 
is omitted for clarity. Displacement ellipsoids are drawn at 50% probability level and H 
atoms are represented by spheres of arbitrary size. 
 
 
 
 
 
 
 
 
 
 
 
 
3 
Supplementary Information 
S16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S2. Silver(I) complex 3 stability over time measured by 
1
H NMR spectroscopy. 
1
H 
NMR spectrum was measured immediately (a) and 48 h (b) after complex dissolution in 
DMSO-d6. 
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Fig. S3. Air/light stability of silver(I) complexes 1 – 5. 
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Fig. S4. The most stable binding of the tested compounds to base pairs of DNA and the 
corresponding binding energies, as assessed by molecular docking. 
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Fig. S5. The heartbeating rate of zebrafish embryos at 114 hpf upon different 
concentrations of complex 1, 1,7-phen and silver(I) sulfadiazine (AgSD). Statistically 
significant differences between data of untreated control and treatments were denoted with 
asterisk (*P < 0.5, **P < 0.01; ***P < 0.001; Student t’ test). 
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Table S1  
Selected bond distances (Å) and valence angles (
o
) in the silver(I) complexes 1, 3 and 4. 
 1 3 4 
Ag—N1 2.203(4) 2.137(10) 2.172(7) 
Ag—N3 2.206(4) 2.146(9) 2.191(7) 
Ag—O2 2.630(4) / / 
Ag—O3 2.652(4) / / 
    
N1—Ag—N3 154.78(15) 174.2(3) 166.6(3) 
N1—Ag—O3 95.33(15) / / 
N3—Ag—O2 93.83(15) / / 
O2—Ag—O3 47.85(12) / / 
N1—Ag—O2 110.83(15) / / 
N3—Ag—O3 105.53(15) / / 
N5—O3—Ag 95.1(3) / / 
N5—O2—Ag 95.8(3) / / 
C1—N1—Ag 120.6(3) 118.4(8) 121.5(6) 
C5—N1—Ag 121.8(3) 121.7(8) 119.6(5) 
C13—N3—Ag 119.5(3) 119.2(8) 119.1(6) 
C17—N3—Ag 122.7(3) 120.1(7) 120.1(5) 
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Table S2 
Details of the crystal structure determinations of the silver(I) complexes 1, 3 and 4. 
 1 3 4 
Empirical formula C24H16AgN5O3 C25H16AgF3N4O3S C24H16AgBF4N4 
CCDC number CCDC-1829501 CCDC-1829502 CCDC-1829503 
Formula weight (g.mol
-1
) 530.29 617.35 555.09 
Crystal system, space group triclinic, Pī triclinic, Pī triclinic, Pī 
a (Å) 7.1629(7) 6.9800(5) 7.1759(8) 
b (Å) 10.5142(9) 13.6380(9) 10.9209(12) 
c (Å) 14.5205(12) 13.9579(9) 14.5568(15) 
 (°) 78.215(7) 109.122(5) 83.120(9) 
  (°) 81.410(7) 103.327(5) 86.671(9) 
  (°) 73.611(7) 103.352(5) 71.989(9) 
V (Å
3
) 1022.11(16) 1151.72(14) 1076.8(2) 
F000 532 616 552 
 2 2 2 
X-radiation,  /Å Mo-Kα 0.71073 Mo-Kα 0.71073 Mo-Kα 0.71073 
data collect. temperat.  /K 298(2) 298(2) 250(2) 
Calculated density (Mg m
-3
) 1.723 1.780 1.712 
Absorption coefficient  (mm
-1
) 1.026 1.028 0.991 
Crystal size (mm) 0.400 × 0.100 × 0.020 0.29 x 0.13 x 0.04 0.210 × 0.130 × 0.030 
 range  (°) 1.4 to 25.2 1.6 to 25.1 1.4 to 25.3 
index ranges h, k, l -8 ... 8, -12 ... 12, -17 ... 17 -7 … 8, -16… 16, -16... 16 -8 ... 8, -13 ... 13, -4 ... 17 
No. of collected and independent 
reflections 
13116, 3640 14162, 4106 3842, 3842 
Rint 0.1022 0.1034   
Data / restraints / parameters 3640 / 0 / 298 4106/151/334 3842 / 0 / 308 
Goodness-on-fit on F
2
 0.990 0.993 0.915 
Final R indices 
 [Fo > 4 (Fo)] R(F), wR(F
2
) 
0.0481, 0.1111 0.0868, 0.2212 0.0699, 0.1669 
Final R indices 
 (all data) R(F), wR(F
2
) 
0.0741, 0.1237 0.1638, 0.2838 0.1335, 0.2031 
Difference density: max, min (e Å
-3
) 1.06, -0.62 2.03, -0.66 0.68, -0.65 
Twinned Data Refinement / / 0.674(4), 0.326(4) 
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Table S3 
Lethal and teratogenic effects observed in zebrafish (Danio rerio) embryos at different 
hours post fertilization (hpf). 
Category   Developmental endpoints  Exposure time (hpf) 
    24  48  72  96/114 
        Lethal effect  Egg coagulation
a
  ● ● ● ● 
  No somite formation  ● ● ● ● 
  Tail not detached  ● ● ● ● 
  No heartbeat   ● ● ● 
        
Teratogenic effect  Malformation of head  ● ● ● ● 
  Malformation of eyes
b
  ● ● ● ● 
  Malformation of sacculi/otoliths
c
  ● ● ● ● 
  Malformation of chorda  ● ● ● ● 
  Malformation of tail
d
  ● ● ● ● 
  Scoliosis  ● ● ● ● 
  Heartbeat frequency   ● ● ● 
  Blood circulation   ● ● ● 
  Pericardial edema  ● ● ● ● 
  Yolk edema  ● ● ● ● 
  Yolk absosrption  ● ● ● ● 
  Growth retardation
e
  ● ● ● ● 
a
No clear organs structure is recognized. 
b
Malformation of eyes was recorded for the retardation in eye development and abnormality in 
shape and size. 
c
Presence of no, one or more than two otoliths per sacculus, as well as reduction and enlargement 
of otoliths and/or sacculi (otic vesicles). 
d
Tail malformation was recorded when the tail was bent, twisted or shorter than to control embryos 
as assessed by optical comparation. 
e
Growth retardation was recorded by comparing with the control embryos in development or size 
(before hatching, at 24 and 48 hpf) or in a body length (after hatching, at and onwards 72 hpf) using 
by optical comparation using an inverted microscope (CKX41; Olympus, Tokyo, Japan). 
 
 
 
 
 
 
 
 
